Autolus Therapeutics plc (AUTL) Share-based Payment Arrangement, Expense USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Autolus Therapeutics plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2024.
  • Autolus Therapeutics plc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $2.28 M, a 5.46% decline year-over-year.
  • Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2023 was $11.3 M, a 6.36% decline from 2022.
  • Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2022 was $12 M, a 20.9% increase from 2021.
  • Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2021 was $9.94 M, a 50.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.28 M -$132 K -5.46% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q3 2023 $2.86 M -$473 K -14.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q1 2023 $2.42 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q3 2022 $3.34 M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q1 2021 $13.1 M -$670 K -$6.91 M -111% Jan 1, 2021 Mar 31, 2021 6-K 2021-05-06
Q4 2020 $20 M $4.24 M -$2.21 M -34.3% Oct 1, 2020 Dec 31, 2020 20-F 2023-03-07
Q3 2020 $22.2 M $4.25 M -$3.46 M -44.9% Jul 1, 2020 Sep 30, 2020 6-K 2020-11-05
Q2 2020 $25.7 M $5.31 M -$3.56 M -40.2% Apr 1, 2020 Jun 30, 2020 6-K 2020-08-06
Q1 2020 $29.3 M $6.24 M -$1.13 M -15.3% Jan 1, 2020 Mar 31, 2020 6-K 2021-05-06
Q4 2019 $30.4 M $6.45 M +$3.05 M +90% Oct 1, 2019 Dec 31, 2019 20-F 2022-03-10
Q3 2019 $27.3 M $7.71 M Jul 1, 2019 Sep 30, 2019 6-K 2020-11-05
Q2 2019 $8.87 M +$6.49 M +273% Apr 1, 2019 Jun 30, 2019 6-K 2020-08-06
Q1 2019 $7.37 M Jan 1, 2019 Mar 31, 2019 6-K 2020-05-07
Q4 2018 $3.39 M Oct 1, 2018 Dec 31, 2018 20-F 2021-03-04
Q2 2018 $2.38 M Apr 1, 2018 Jun 30, 2018 6-K 2019-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.